SELECTION OF THERAPEUTIC AGENTS FOR INTRAOCULAR PROLIFERATIVE DISEASE .2. DIFFERING ANTIPROLIFERATIVE ACTIVITY OF THE FLUOROPYRIMIDINES

被引：42

作者：

BLUMENKRANZ, MS

HARTZER, MK

HAJEK, AS

机构：

[1] OAKLAND UNIV,EYE RES INST,ROCHESTER,MI 48063

[2] UNIV MIAMI,SCH MED,BASCOM PALMER EYE INST,DEPT OPHTHALMOL,MIAMI,FL 33152

[3] WILLIAM BEAUMONT HOSP,ROYAL OAK,MI 48072

来源：

ARCHIVES OF OPHTHALMOLOGY | 1987年 / 105卷 / 03期

关键词：

D O I：

10.1001/archopht.1987.01060030116039

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：396 / 399

页数：4

共 29 条

[21]

Miller E, 1971, J Surg Oncol, V3, P309, DOI 10.1002/jso.2930030311

[22]

MYERS CE, 1981, PHARMACOL REV, V33, P1

[23]

OLSEN KE, 1984, INVEST OPHTHALMOL VI, V25, P84

[24]

ROOTMAN J, 1979, ARCH OPHTHALMOL-CHIC, V97, P2375

[25] PHARMACOKINETICS OF 5-FLUOROURACIL - INTERRELATIONSHIP WITH BIOCHEMICAL KINETICS IN MONITORING THERAPY [J].

SADEE, W ;

WONG, CG .

CLINICAL PHARMACOKINETICS, 1977, 2 (06) :437-450

[26] FLUOROURACIL THERAPY FOR PROLIFERATIVE VITREORETINOPATHY AFTER VITRECTOMY [J].

STERN, WH ;

LEWIS, GP ;

ERICKSON, PA ;

GUERIN, CJ ;

ANDERSON, DH ;

FISHER, SK ;

ODONNELL, JJ .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1983, 96 (01) :33-42

[27] EFFECTS OF CYTO-TOXIC DRUGS ON PROLIFERATIVE VITREORETINOPATHY IN THE RABBIT-CELL INJECTION MODEL [J].

SUNALP, M ;

WIEDEMANN, P ;

SORGENTE, N ;

RYAN, SJ .

CURRENT EYE RESEARCH, 1984, 3 (04) :619-623

[28]

Walsh PM, 1985, INVEST OPHTHALMOL S, V26, P191

[29] CONTROL OF EXPERIMENTAL MASSIVE PERIRETINAL PROLIFERATION BY DAUNOMYCIN - DOSE-RESPONSE RELATION [J].

WIEDEMANN, P ;

KIRMANI, M ;

SANTANA, M ;

SORGENTE, N ;

RYAN, SJ .

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1983, 220 (05) :233-235

← 1 2 3 →